The purpose of this study is to learn whether growth hormone being administered to children with Chronic Kidney Disease is effective and if it has any side effects.
Study Type
OBSERVATIONAL
Enrollment
27
UC Davis Medical Center
Sacramento, California, United States
The primary outcome measures of the NCGS are ongoing safety and efficacy of Genentech GH preparations in pediatric growth disorders for which GH is initiated.
Time frame: per the study, the pt will be on GH treatement until the physician instructs them to stop
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.